Editorial: Reviews in pharmacology of anti-cancer drugs: 2023

Oncological research represents a cornerstone in the global effort to reduce the burden of cancers that are characterized by marked biological complexity and heterogeneity (Ng and Shaffer, 2023; Imodoye et al., 2024). A multifaceted strategy is required to address the aforementioned crictisms, drawing on approaches of molecular and cell biology, genomics, immunology, pharmacology, drug delivery and public health (Liu et al., 2024; Ammar et al., 2025). Each of them provides distinct and complementary insights, allowing a more holistic understanding of tumor development, progression, and response to therapies. In addition, the integration of various methodological approaches—ranging from in vitro and in vivo studies to clinical trials and epidemiological investigations—enhances the robustness and translational potential of research findings. The interdisciplinary paradigm has proven essential for fostering innovation and for the development of innovative diagnostic and therapeutic therapies in oncology (Mäurer et al., 2023; Grillone et al., 2024).